Why ROI Measurement in Connected Product Strategies Demands Senior Customer-Support Attention

Connected products in clinical research—wearables, remote monitoring devices, eConsent tools—offer rich data streams. Yet, the challenge is quantifying their true impact on support operations and trial outcomes. As a senior customer-support leader, your goal isn’t just adopting shiny tech; it’s proving that these investments improve trial retention, reduce support tickets, or cut down site monitoring calls. Without robust ROI measurement, these initiatives risk becoming costly experiments.

Below are nine strategies grounded in direct experience from three clinical-research companies, emphasizing practical metrics, dashboards, and reporting frameworks you can apply. Some ideas will challenge conventional wisdom, others highlight surprising pitfalls.

1. Anchor ROI Metrics to Trial-Specific Clinical Outcomes, Not Just Device Uptime

The default in many connected product implementations is tracking device connectivity or app crash rates. Those matter, but they don’t prove value. What senior support teams must do is connect technology data to clinical KPIs such as patient retention rates, protocol adherence, or data query reductions.

Example: At one mid-sized biotech, linking remote device data quality to a 7% improvement in patient adherence translated to $150k saved in extended site visits over 12 months.

This connection forces collaboration beyond support—into clinical operations and data management—to align on what matters.

Caveat: This approach demands upfront agreement on outcome metrics, which can delay rollouts if stakeholders aren’t aligned.

2. Use Consent Management Platforms to Reduce Support Tickets and Track Consent Compliance

Consent management platforms (CMPs) are often sold as compliance tools but overlook their value in reducing support friction. By automating consent versions and reminders, support tickets related to patient confusion or consent validity drop significantly.

An internal review at a pharma CRO revealed a 40% reduction in consent-related inquiries after deploying a CMP integrated with the support ticketing system. The reporting dashboard pulled consent status in real-time, empowering reps to resolve queries faster.

Tip: Tools like Zigpoll, DocuSign CLM, and OneTrust CMP can be integrated with support dashboards to visualize consent bottlenecks.

Limitation: For trials with decentralized populations, CMPs may not eliminate all consent issues, especially if patients struggle with digital literacy.

3. Prioritize Dashboards That Combine Patient-Reported Outcomes (PROs) With Support Volume

Clinical research teams obsess over PRO trends but rarely examine how support volume fluctuates alongside patient symptom reports or device alerts. Building a combined dashboard revealed unexpected spikes in support tickets when PRO scores dipped below predetermined thresholds.

One oncology trial team saw a doubling of support calls during PRO score declines, indicating patients needed faster intervention or education. This insight led to proactive outreach protocols that decreased emergency visits by 12%, translating to notable cost avoidance.

Why this works: It shifts support from reactive troubleshooting to trending analysis, making your team a strategic clinical partner.

4. Don’t Rely Solely on NPS for Support Impact; Use Targeted, Continuous Feedback Tools

Net Promoter Score (NPS) often feels like a vanity metric, especially in healthcare trials where patient experience nuances matter. Instead, senior support teams should use continuous micro-surveys embedded within apps or communication channels to capture consent clarity, device ease, and symptom management satisfaction.

Zigpoll and Medallia offer efficient micro-survey solutions tailored for healthcare settings, enabling you to tie feedback directly to specific connected product interactions. This real-time data can be visualized alongside trial milestones for granular stakeholder reporting.

Note: Surveys must be brief and multilingual to avoid patient fatigue and bias.

5. Realize That ROI Calculations Must Account for Training and Change Management Costs

It’s tempting to report ROI based solely on reduced support inquiries or faster resolutions. However, connected products often require significant upfront investments in staff training, patient education, and change management that must be amortized.

At one global CRO, the total cost to train support and clinical staff on a connected inhaler device was nearly 25% of the first-year benefits realized from reduced site visits. Factoring in these “hidden” costs provided a more realistic ROI that informed future product rollouts.

Implication: Tracking training hours and associated costs in your dashboards helps present a more balanced, trustworthy ROI figure to executives.

6. Use Cohort Analysis to Isolate Connected Product Impact From Other Variables

Clinical trials are complex, with many moving parts influencing support and clinical outcomes. Simply comparing pre- and post-product metrics leads to misleading conclusions.

One effective technique is cohort analysis—comparing patients with and without connected devices in the same trial phase, matched by demographics and site. This method uncovered a 15% lower dropout rate for device users, a finding masked in aggregate data.

Bottom line: When available, use cohort data to isolate the true incremental benefit of connected products on support load and patient experience.

7. Integrate Consent and Device Data Into Unified Reporting for Stakeholders

Siloed data kills clarity. We found that integrating consent status, device usage, and support ticket volume into a single reporting platform made a huge difference when presenting ROI to sponsors.

A combined dashboard enabled monthly deep dives, where stakeholders could track correlations like expired consents causing device lockout errors and subsequent ticket surges.

Platforms like Tableau, Power BI, or custom-built portals have proven invaluable here, though the investment can be high.

Trade-off: Expect initial data integration challenges and ongoing maintenance efforts.

8. Recognize When Connected Products May Not Yield ROI in Complex Patient Populations

Connected product enthusiasm can blind teams to real-world limits, particularly in elderly or low-technology-literacy patient groups. One clinical trial of heart failure patients found that 30% of enrolled participants never activated the remote monitoring device, limiting ROI.

In such cases, ROI efforts should shift towards hybrid models combining connected and traditional data collection approaches, with tailored support workflows.

Key takeaway: Always pilot connected products with representative patient subsets before full deployment to validate ROI assumptions.

9. Use Predictive Analytics to Forecast Support Load and ROI for Future Trials

The final frontier is predicting ROI before committing. Advanced analytics applied to historical support ticket data, device usage logs, and consent management records can help forecast future support volumes and expected cost savings.

At a mid-size CRO, predictive models reduced support staffing mismatches by 18%, improving trial efficiency. Importantly, these models highlighted when connected product investments were unlikely to pay off, guiding smarter portfolio decisions.

Tip: Collaborate with data scientists and use platforms with embedded predictive capabilities to build these forecasts.

Prioritization Advice for Senior Customer-Support Leaders

Start by mapping connected product metrics to clinical trial outcomes important to your stakeholders (strategy #1). Simultaneously, integrate consent management insights to reduce support friction (#2 and #7). Avoid over-reliance on traditional satisfaction scores; instead, deploy targeted continuous feedback (#4). Always include training and change management costs in your ROI estimates (#5). Finally, pilot connected products with representative users and use cohort analysis to validate benefits (#6 and #8).

With this approach, your ROI narratives gain credibility, supporting smarter investments and demonstrating the vital role of customer support in clinical product strategy success.